VANGUARD GROUP INC - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 2 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$65,000
-56.1%
591,5880.0%0.00%
Q2 2022$148,000
-15.4%
591,5880.0%0.00%
Q1 2022$175,000
-21.5%
591,5880.0%0.00%
Q4 2021$223,000
-28.5%
591,588
+22.0%
0.00%
Q3 2021$312,000
-4.3%
485,0330.0%0.00%
Q2 2021$326,000
-13.3%
485,033
+17.3%
0.00%
Q1 2021$376,000
+235.7%
413,541
+158.1%
0.00%
Q4 2020$112,000
+0.9%
160,224
+5.2%
0.00%
Q3 2020$111,000
-19.6%
152,309
+26.7%
0.00%
Q2 2020$138,000
+228.6%
120,224
+71.4%
0.00%
Q1 2020$42,000
+110.0%
70,124
+121.0%
0.00%
Q4 2019$20,000
+5.3%
31,726
+1.3%
0.00%
Q3 2019$19,000
-62.7%
31,326
+4.7%
0.00%
Q2 2019$51,000
+30.8%
29,926
-7.5%
0.00%
Q1 2019$39,000
+69.6%
32,340
+9.5%
0.00%
Q4 2018$23,000
-54.9%
29,529
+9.7%
0.00%
Q3 2018$51,000
-23.9%
26,9100.0%0.00%
Q2 2018$67,000
-31.6%
26,910
-5.0%
0.00%
Q1 2018$98,000
+66.1%
28,330
+82.7%
0.00%
Q4 2017$59,000
-56.0%
15,510
-46.5%
0.00%
Q3 2017$134,000
+31.4%
29,013
+9.2%
0.00%
Q2 2017$102,000
+4.1%
26,562
+0.0%
0.00%
Q1 2017$98,000
+11.4%
26,5610.0%0.00%
Q4 2016$88,000
-20.0%
26,5610.0%0.00%
Q3 2016$110,000
+144.4%
26,561
+49.0%
0.00%
Q2 2016$45,000
+18.4%
17,8230.0%0.00%
Q1 2016$38,000
-51.9%
17,823
-54.2%
0.00%
Q4 2015$79,00038,9470.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 52,301$36,0000.00%
TOWNSQUARE CAPITAL LLC 53,672$37,0000.00%
REILLY FINANCIAL ADVISORS, LLC 17,500$12,0000.00%
NVWM, LLC 2,997$2,0000.00%
Advisory Services Network, LLC 20,500$14,0000.00%
VANGUARD GROUP INC 160,224$112,0000.00%
UBS Group AG 10,353$7,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 25,000$17,0000.00%
Sugarloaf Wealth Management, LLC 2,000$1,0000.00%
OSAIC HOLDINGS, INC. 3,260$3,0000.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders